PARABILIS MEDICINES (PBLS) Stock Price, News & Analysis
Company Description
PARABILIS MEDICINES (NASDAQ: PBLS) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $3.9B, ranking #1,735 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for PBLS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PARABILIS MEDICINES (PBLS) stock last closed at $31.96. At a market capitalization of $3.9B, PBLS is classified as a mid-cap stock with approximately 120.7M shares outstanding.
Latest News
PARABILIS MEDICINES has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include IPO, offering. View all PBLS news →
SEC Filings
PARABILIS MEDICINES has filed 5 recent SEC filings, including 3 Form 4, 1 Form 3, 1 Form SCHEDULE 13D. The most recent filing was submitted on July 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PBLS SEC filings →
Insider Radar
Insider buying activity at PARABILIS MEDICINES over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Short interest in PARABILIS MEDICINES (PBLS) currently stands at 4.0 million shares, up 42.8% from the previous reporting period, representing 11.8% of the float. Since June 2026, short interest has increased by 254.2%. This moderate level of short interest indicates notable bearish positioning. The 8.3 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for PARABILIS MEDICINES (PBLS) currently stands at 8.3 days, up 220.5% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 524.1% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.3 to 8.3 days.
PBLS Company Profile & Sector Positioning
PARABILIS MEDICINES (PBLS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #183 among all tracked companies.